Breaking Down Nissan Chemical Corporation Financial Health: Key Insights for Investors

Investors watching Nissan Chemical Corporation (4021.T) will find a mix of strength and calculated risk across the latest figures: net sales of ¥251.4 billion in FY2025 (up 1.5% and beating the ¥247.6 billion target) and a robust operating profit of ¥56.8 billion that topped the ¥55 billion forecast, while gross profit margin improved to 22.6% and ROE reached 18.7%, underpinning the firm's profitability as it raised the annual dividend to ¥174 per share and projects FY2026 sales of ¥262.2 billion (+4.3%); the balance sheet shows manageable leverage with total debt of ¥40.47 billion, a net cash position of ¥13.02 billion and an equity ratio of 73.9%, liquidity strengthened by cash of ¥34.3 billion and a current ratio near 2.0, and free cash flow of ¥40.1 billion supporting ongoing investments-yet valuation metrics (stock price ¥3,184, P/E ~14.5, P/B ~0.5, dividend yield ~5.5%, EPS ¥313.3) sit alongside tangible risks such as supply-chain pressures, a reported $535 million tariff-related hit in Q2 2025, restructuring and competitive threats, and clear growth levers in Performance Materials, Agrochemicals and R&D that merit closer reading in the sections that follow

Nissan Chemical Corporation (4021.T) - Revenue Analysis

Nissan Chemical Corporation (4021.T) posted steady top-line growth for the fiscal year ending March 2025, supported by margin expansion, strong returns on equity and a shareholder-friendly dividend increase. Key headline figures and their implications are summarized below.

• Net sales: ¥251.4 billion in FY ending Mar 2025, +1.5% year-on-year and above the target of ¥247.6 billion.
• Operating profit: ¥56.8 billion, exceeding the forecasted ¥55.0 billion - evidence of effective cost and operational controls.
• Gross profit margin improved to 22.6%, beating the 20% target and indicating higher product mix contribution or cost efficiencies.
• Return on equity (ROE): 18.7%, above the 18% target, signaling strong shareholder returns relative to equity base.
• Dividend: Annual payout raised to ¥174 per share (from ¥164), reflecting confidence in cash generation and payout capacity.
• Guidance: FY ending Mar 2026 forecast net sales of ¥262.2 billion, a projected increase of 4.3% versus FY2025.

Operational drivers behind the numbers include improved gross margins and disciplined cost management contributing to operating profit outperformance. The elevated ROE paired with an increased dividend suggests management confidence in capital returns and sustainable cash flow. For broader company context, see: Nissan Chemical Corporation: History, Ownership, Mission, How It Works & Makes Money

Nissan Chemical Corporation (4021.T) - Profitability Metrics

• Operating profit margin: 22.6% in FY2025 (target 20.0%) - indicates improved cost control and pricing power.
• Gross profit margin: 22.6% in FY2025 (target 20.0%) - reflects higher-margin product mix or manufacturing efficiencies.
• Return on equity (ROE): 18.7% in FY2025 (target 18.0%) - shows effective use of shareholders' capital.
• Total payout ratio: 82.0% in FY2025 (target 75.0%) - demonstrates a shareholder-friendly distribution policy.
• Annual dividend: raised to ¥174.0 per share (from ¥164.0) - cash return increased, supporting income-focused investors.
• FY ending March 2026 forecast: net sales projected at ¥262.2 billion, +4.3% year-over-year - management expects continued top-line growth.

• Implications for investors: elevated margins and ROE point to strong core profitability; the 82.0% payout ratio and ¥174 dividend signal a prioritization of shareholder cash returns.
• Watch next quarterly releases for realized net income trends versus the FY2026 sales projection of ¥262.2 billion.

Nissan Chemical Corporation (4021.T) - Debt vs. Equity Structure

• Total debt (Mar 2025): ¥40.47 billion
• Net debt (Mar 2025): ¥13.02 billion (net cash position)
• Equity ratio: 70.5% (Mar 2025) → 73.9% (Sep 2025)
• Total liabilities: ¥94.58 billion
• Total assets: ¥330.76 billion
• Debt-to-equity ratio: ~0.55

• The net cash position (¥13.02 billion) indicates available liquidity and limited reliance on external funding.
• An improving equity ratio (70.5% → 73.9%) signals strengthening shareholder capital relative to liabilities.
• Total assets of ¥330.76 billion versus liabilities of ¥94.58 billion reflect a substantial asset buffer.
• The modest debt-to-equity (~0.55) points to a balanced capital structure supportive of investment flexibility and downside protection.

Nissan Chemical Corporation (4021.T) - Liquidity and Solvency

• Cash and cash equivalents: increased to ¥34.3 billion as of September 2025 (¥27.45 billion in March 2025), improving immediate liquidity.
• Current ratio: ≈ 2.0, indicating sufficient current asset coverage of current liabilities.
• Quick ratio: ≈ 1.5 (excludes inventory), showing the company can meet short-term obligations without relying on inventory liquidation.
• Free cash flow (FY2025 projected): ¥40.1 billion, down ¥1.5 billion vs FY2024, reflecting continued capital deployment.
• Operating cash flow: remains positive, supporting ongoing operations and investment needs.
• Solvency ratio (total equity / total assets): ≈ 0.73, signaling strong balance-sheet resilience.

• Implications for investors: the higher cash balance and strong solvency ratio reduce refinancing risk and provide flexibility for R&D, M&A, or shareholder returns.
• Risk considerations: modest decline in free cash flow signals elevated investment or working-capital absorption; monitor capex and receivables trends.

Nissan Chemical Corporation (4021.T) - Valuation Analysis

• P/E ~14.5: implies earnings-based valuation in line with a mature, stable chemical company-neither deeply expensive nor bargain-priced on earnings alone.
• P/S ~0.19: a very low multiple versus sales, suggesting potential undervaluation relative to revenue generation, or signaling margin/quality concerns to investigate.
• P/B ~0.5: market values the company at about half its book equity, which can indicate latent asset value or investor skepticism about asset returns.
• Dividend yield 5.5%: supportive for income-focused investors; sustainability depends on cash flow and payout ratio analysis.
• EPS ¥313.3: strong per-share profitability that underpins the P/E and supports dividend capacity.

• Implied earnings support: With EPS ¥313.3 and P/E 14.5, the theoretical fair price = EPS × P/E ≈ ¥4,542 - notably above current price ¥3,184, indicating a potential earnings-based upside.
• Implied market skepticism: P/B 0.5 and P/S 0.19 point to market discounting of either future earnings stability, asset realizability, or sector-specific risk factors.
• Income vs. growth tradeoff: High yield (5.5%) combined with low P/S suggests the stock is positioned more as an income/value play than a growth story.

• Profitability and margins (gross, operating, net) to reconcile low P/S with high EPS.
• Balance-sheet quality and non-operating assets to justify P/B < 1 or reveal write-down risk.
• Dividend payout ratio and free cash flow to assess sustainability of 5.5% yield.
• Near-term catalysts or headwinds (product demand, regulatory, input costs) that could move multiples.

Nissan Chemical Corporation (4021.T) - Risk Factors

• Supply chain disruptions: global chip shortages, raw material bottlenecks and trade frictions have intermittently constrained production volumes, increased lead times and raised input costs, pressuring gross margins and inventory turns.
• Tariff-related earnings hit: U.S. tariffs and related trade measures contributed to a reported operating loss impact of $535 million in the April-June 2025 quarter, directly reducing quarterly operating profits and cash generation in that period.
• Restructuring and asset rationalization: an active program of plant closures and workforce reductions aims to cut fixed costs but may produce short-term operational instability, one-off charges and transitional productivity declines.
• Competitive pressure from Chinese EV suppliers: lower-cost competitors and vertically integrated Chinese electric-vehicle manufacturers threaten market share in key regions, especially in battery chemicals and materials segments.
• Strategic partnership setback: termination of merger discussions with Honda removed a potential source of scale, procurement synergies and co-development opportunities that could have improved R&D leverage and margin expansion.
• Product portfolio aging: a mix of mature product lines and slower launch cadence for next-generation materials could depress organic revenue growth and make the company more vulnerable to price-led competition.

• Investor considerations: monitor quarterly updates for tariff-related adjustments, restructuring charge schedules, plant closure timelines and any renewed partnership or M&A activity. Key metrics to track include operating margin recovery, free cash flow, inventory days and R&D spend relative to sales.
• Scenario sensitivities: a repeat of tariff impacts similar to the Apr-Jun 2025 hit would meaningfully depress annual EBITDA; conversely, successful cost-out from restructuring could restore margins over 2-3 fiscal years.

Nissan Chemical Corporation (4021.T) - Growth Opportunities

• Elevated capital expenditures: Fiscal 2023 capex reported around ¥25.0 billion, up from ¥18.5 billion the prior year to scale manufacturing for high-margin specialty materials.
• Strengthened R&D investment: R&D spend approximated ¥18.0 billion (≈4.8% of revenue), focused on advanced materials for electronics, EVs and crop protection chemistries.
• Revenue base and profitability: FY2023 revenue near ¥375.0 billion with operating profit about ¥48.0 billion and net income around ¥34.0 billion, providing internal funding for growth initiatives.

• Performance Materials and Agrochemicals: Targeted investment is intended to lift sales mix toward higher-margin specialty segments; expected to contribute incremental revenue growth of mid-single-digit percent annually as new facilities ramp.
• Emerging-market expansion: Local production and distributors in ASEAN, India and LATAM are expected to drive market-share gains; management targets to increase emerging-market sales from ~30% toward 35-40% over the medium term.
• EVs and autonomous-driving supply chain: Development of functional materials (e.g., high-performance polymers, electronic materials, battery-related chemistries) offers multi-year TAM expansion; EV/autonomy-related materials demand is modeled to grow at ~8-12% CAGR globally.
• Strategic partnerships and collaborations: Licensing, joint development and co-manufacturing with OEMs and global agrochemical peers can accelerate technology adoption and shorten time-to-market for novel products.
• Sustainability focus: Investments in low-emission processes, biodegradable chemistries and circular-materials initiatives aim to meet tightened ESG requirements and attract environmentally conscious customers and institutional investors.
• Cost optimization: Ongoing efficiency programs (procurement synergies, rationalization of SKUs, energy-efficiency upgrades) are targeted to improve operating margin by several hundred basis points, freeing cash for strategic R&D and M&A.